IBI-325

CAT: 0804-HY-P991634Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-P991634Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
IBI-325 is a humanized monoclonal antibody inhibitor targeting CD73. IBI-325 completely inhibits CD73 enzymatic activity without hook effect. IBI-325 reverses Adenosine monophosphate (HY-A0181) -mediated immune suppression and significantly inhibits T cell proliferation and cytokines (IL-2, IFN-γ and TNF-α) release. IBI-325 has potent antitumor activities in hPBMC-reconstituted mice model and hCD73 knock-in mice model. IBI-325 can be used for cancer immunotherapy research[1].
UNSPSC
12352100
Target
CD73; IFNAR; Interleukin Related; TNF Receptor
Related Pathways
Apoptosis; Immunology/Inflammation
Field of Research
Cancer; Inflammation/Immunology
References & Citations
[1]Zhou Y, et al. Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy. Int J Biol Macromol. 2023 Feb 28;229:158-167.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
IL-2

Related Products

CatalogName
HY-P991366IBI-397
HY-P991740IBI-363
HY-P991092IBI-334
HY-P990312-01ABT-325
HY-119229-01VRT-325
HY-103706-01ROC-325
HY-179211CliMB-325
HY-W952727CRBN ligand-325
HY-R00683-01Hsa-miR-325 mimic
HY-P5502Influenza NP (311-325)

Alternative Products

CatalogName
MF-0101021-01IBI-325
HB209186-01Anti-Human CD73/NT5E Reference Antibody (IBI-325)
MF-0100762-01IBI-322
MF-0100760-01IBI-397
MF-0101344-01IBI-334
IB47602IBI ISOLATE TOTAL EXTRACTION
IB70070IBI BASIC AGAROSE-100GM
IB56000IBI HR2025 HORIZONTAL UNIT
IB51000IBI QS710 HORIZONTAL UNIT
IB70072IBI BASIC AGAROSE-500GM

Popular Products